- NEWS EXPLAINER
- Update 05 December 2025
Hepatitis B vaccine guidance set to be rolled back for US babies: what the science says
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-025-03937-1
Additional reporting by Traci Watson
Updates & Corrections
-
Update 05 December 2025: This story was updated 5 December with the results of the vaccine panel’s vote.
References
Abers, M. S., Ulrich, A. K. & Walensky, R. P. JAMA https://doi.org/10.1001/jama.2025.24996 (2025).
Scheiblauer, H. et al. Vox Sang. 98, 403–414 (2010).
Pham, T. T. H. et al. Am. J. Prev. Med. 65, 52–59 (2023).
Bond, W. W. et al. Lancet 317, 550–551 (1981).
Bixler, D., Barker, L., Lewis, K., Peretz, L. & Teshale, E. Hepatol. Commun. 7, e0118 (2023).
RFK Jr’s vaccine advisers vote down flu-shot ingredient — but back some jabs
How to stop mother-to-child transmission of hepatitis B
Facing the challenge of eliminating hepatitis B
154 million lives and counting: 5 charts reveal the power of vaccines